Prevalence of metformin use 0.7 percent in prediabetes
(HealthDay)—For U.S. adults with prediabetes, the prevalence of metformin use is 0.7 percent, according to a study published online April 3 in Diabetes Care.
Apr 7, 2017
0
0
(HealthDay)—For U.S. adults with prediabetes, the prevalence of metformin use is 0.7 percent, according to a study published online April 3 in Diabetes Care.
Apr 7, 2017
0
0
Researchers continue to gather evidence that exercise can serve as a supplement to, or even a replacement for, drugs in their efforts to combat specific illnesses. With $3.6 million in funding from the National Institutes ...
Apr 5, 2017
1
0
In the last three years, researchers have shown that diabetic patients with head and neck cancer, may have better outcomes than non-diabetic patients when they are taking the drug metformin for their diabetes. In order to ...
Jan 25, 2017
0
2
(HealthDay)—For patients with long-standing poorly controlled type 2 diabetes mellitus (T2DM) on metformin plus a sulfonylurea, combination therapy with exenatide and pioglitazone is effective and safe, according to a study ...
Jan 23, 2017
0
0
(HealthDay)—For patients with gestational diabetes mellitus (GDM), glyburide and metformin are comparable in terms of glucose control and safety, according to a study published online Jan. 11 in Diabetes Care.
Jan 17, 2017
0
0
(HealthDay)—For patients with chronic kidney disease (CKD), congestive heart failure (CHF), or chronic liver disease (CLD) with hepatic impairment, metformin use is associated with improvements in clinical outcomes, according ...
Jan 4, 2017
0
3
(HealthDay)—Newly updated guidelines reaffirm that metformin is the first-line drug for people with type 2 diabetes, and that several other medications—including newer ones—can be added if needed.
Jan 3, 2017
0
50
Physicians should prescribe metformin to patients with type 2 diabetes when medication is needed to improve high blood sugar, the American College of Physicians (ACP) recommends in an evidence-based clinical practice guideline ...
Jan 2, 2017
0
2
(HealthDay)—The growth differentiation factor 15 (GDF15) is a novel biomarker for the use and dosing of metformin, according to a study published online Dec. 14 in Diabetes Care.
Dec 21, 2016
0
0
Considerable evidence has indicated that the drug metformin, used for more than 50 years to treat type 2 diabetes, also can prevent or slow the growth of certain cancers; but the mechanism behind its anticancer effects has ...
Dec 15, 2016
0
214